Global Ganja Report

President José Mujica signed Uruguay's cannabis legalization bill into law on Christmas Eve, and the country's neighbors are preparing for the new policy to take effect—apparently with more trepidation than hope. Mujica is said to have discussed the question with Brazil's center-left President Dilma Rousseff on his visit last month to Brasília. Local media reported that she expressed fears about Uruguayan herb entering Brazil, and announced plans to beef up searches at the border—with plans to impose stiff sentences of 10 years and up for trafficking (including "transnational" personal possession).

Uruguayan President José Mujica on Dec. 24 signed into law his plan to oversee the production and sale of cannabis in the Southern Cone country. The Uruguayan Senate passed the measure to legalize production, sale and consumption of the herb earlier this month. The law makes Uruguay the first country to have a system to regulate cannabis production and sale; use of cannabis was already legal in Uruguay. The bill allows individuals over 18 to grow up to six of their own plants per person, creates state-supervised and controlled consumer clubs, and permits consumers to buy up to 40 grams per month from pharmacies. Uruguay's government has four months to draw up regulations for the program, such as how production licenses will be granted. The International Narcotics Control Board (INCB), the UN body overseeing the implementation of international drug treaties, has criticized Uruguay's legislation as being illegal (PDF) under international treaties. (Jurist, AP, Dec. 25)

Costa Rica's authorities announced 17 raids by the elite Drug Control Police across the Caribbean provinces of Limón and  Cahuita as well as locations in the capital San José Dec. 17, that they boast resulted in the dismantling of the most important narco-trafficking operation in the country to date—with ties to Colombia and Jamaica as suppliers of cocaine and cannabis, and Europe as an export destination. Prosecutor General Jorge Chavarria said that among the 12 arrested were two officers of Public Force, the country's national police, and an officer at the Bank of Costa Rica who facilitated laundering of proceeds. The ring was reportedly led by one Rivas Bonilla AKA "Tito" or "Patrón"—who kept ahead of the law for at least three years through tip-offs from his pal on the police force. Chavarría said that the ring was the largest yet run by Costa Ricans, instead of Colombian or Mexican networks operating within the country. "History has changed," Chavarría said. "We now have Costa Rican groups who want to be entrepreneurs in drugs: owners of the drugs, the organization and the routes."

In an historic move, the American Herbal Pharmacopoeia (AHP) released the first installation of a two-part Cannabis Monograph (PDF) Dec. 10 that classifies marijuana as a botanical medicine, alongside many other widely accepted "Complementary and Alternative Medicines." Written and reviewed by leading experts, the monograph brings together an authoritative compendium of scientific data, including long-awaited standards for the plant's identity, purity, quality and properties. The monograph provides a foundation for health care professionals to integrate cannabis therapy into their practices on the basis of a full scientific understanding of the plant, its constituent components, and its biologic effects.

The past year has seen a spate of dangerous brinkmanship in the Persian Gulf, with Iran and US naval forces along with those of the Gulf's oil-rich Arab mini-states playing chicken over the strategic choke-point of the Strait of Hormuz. But in addition to this show-down over a global oil outlet, the Gulf has seen escalating militarization in the guise of narcotics enforcement. Bahrain's Gulf Daily News on Nov. 26 ran a story boasting of the exploits of a 29-nation Combined Maritime Forces group, based at the petro-kingdom's sprawling US Navy base and commanded by Capt. Robert Slaven of the Royal Australian Navy. While it claims to have "considerably reduced the number of terrorist attacks in the region" over the past decade, it's most concrete gains are hashish and heroin seizures.

Moroccan lawmakers on Dec. 4 opened an unprecedented debate on legalizing medical and industrial uses of cannabis. The discussion of positive uses of cannabis cultivation "in creating an alternative economy" in Morocco, one of the world's top exporters, was convened following a campaign by dissident politicians.  "We are organizing a research day in parliament...on the use of medical kif, with Moroccan and international experts present," said Mehdi Bensaid, an MP with the Party of Authenticity and Modernity (PAM), adding that lawmakers are "looking at controlled rather than total legalization." Activists from Switzerland spoke about their country's experience with a recent decrim law at the session, which Bensaid called "the first step towards a draft law."

Four kayakers attempting to smuggle nearly 300 pounds of cannabis into the US were arrested at sea on the morning of Nov. 22, federal authorities announced. US Customs and Border Patrol agents saw four men in separate kayaks "navigating the ocean" at about 4 AM, agency spokesman Ralph DeSio told the press. The men, all Mexican nationals, had entered US waters off Imperial Beach when authorities dispatched a helicopter and boat to intercept them, DeSio said. The men jumped out and tried to swim for it, but the helicopter used a spotlight to track them so the boat could find them in the dark waters. All the men were taken into custody and turned over to the San Diego Maritime Task Force. Agents found 99 bundles of cannabis in the kayaks, estimated to be worth $178,200.  

British firm GW Pharmaceuticals has won "orphan drug status"—a special category for agents developed to treat rare diseases—from the US Food and Drug Administration (FDA) for Epidiolex, a derivative of cannabidiol (CBD), to treat Dravet syndrome, a severe form epilepsy. In Utah, parents who are lobbying to import CBD-rich cannabis strains from Colorado, say they will keep up their campaign. "This changes nothing" in regard to children being able to access CBD, said Jennifer May, mother of 11-year-old Stockton, who suffers from Dravet syndrome. "On the other hand, it does lend credibility to the potential of CBD as a treatment." Like many Dravet patients, Stockton has tried dozens of pharmaceutical fixes, and run out of options. He can no longer use the toilet and has to be fed from a tube. "Orphan drug" designation qualifies GW for tax credits and exclusive rights to the drug if approved. But FDA approval for Epidiolex could take a year or more. (Salt Lake Tribune, Nov. 18)